Metformin Impact on Progression-Free Survival in Advanced Pancreatic Well-Differentiated Neuroendocrine Tumors (Pwdnets). Retrospective Evaluation in Diabetic Patients Receiving Ev... von Pusceddu, S., De Braud, F.G.M., Concas, L., Bregant, C., Festinese, F., Giacomelli, L., D'Autilia, E., Formisano, B., Mazzaferro, V., Buzzoni, R.

Volltext

1146PMETFORMIN IMPACT ON PROGRESSION-FREE SURVIVAL IN ADVANCED PANCREATIC WELL-DIFFERENTIATED NEUROENDOCRINE TUMORS (PWDNETS). RETROSPECTIVE EVALUATION IN DIABETIC PATIENTS RECEIVI... von Pusceddu, S., De Braud, F.G.M., Concas, L., Bregant, C., Festinese, F., Giacomelli, L., D'Autilia, E., Formisano, B., Mazzaferro, V., Buzzoni, R.

Volltext

Determination of antioxidant efficacy of cosmetic formulations by non-invasive measurements von Vertuani, S., Ziosi, P., Solaroli, N., Buzzoni, V., Carli, M., Lucchi, E., Valgimigli, L., Baratto, G., Manfredini, S.

Volltext

Risk of second primary melanoma: how long should follow-up be? Ratio of observed and expected cases von de Giorgi, V., Rossari, S., Papi, F., Buzzoni, C., Gori, A., Grazzini, M., Savarese, I., Crocetti, E., Longo, A. S., Massi, D.

Volltext

Invasive breast cancer: a significant correlation between histological types and molecular subgroups von Caldarella, A., Buzzoni, C., Crocetti, E., Bianchi, S., Vezzosi, V., Apicella, P., Biancalani, M., Giannini, A., Urso, C., Zolfanelli, F., Paci, E.

Volltext

Post-hoc analysis of CLARINET phase III study to investigate the influence of diabetic status on progression-free survival (PFS) of patients with neuroendocrine tumours (NETs) trea... von Pusceddu, S., Vernieri, C., Di Maio, M., Prinzi, N., Torchio, M., Buzzoni, R., Truong-Thanh, X.-M., Mazzaferro, V., de Braud, F.G.M.

Volltext

Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study von Sant, Milena, Chirlaque Lopez, Maria Dolores, Agresti, Roberto, Sánchez Pérez, Maria José, Holleczek, Bernd, Bielska-Lasota, Magdalena, Dimitrova, Nadya, Innos, Kaire, Katalinic, Alexander, Langseth, Hilde, Larrañaga, Nerea, Rossi, Silvia, Siesling, Sabine, Minicozzi, Pamela

Volltext

Toluene ammoxidation on α-Fe 2O 3-based catalysts von Rombi, E, Ferino, I, Monaci, R, Picciau, C, Solinas, V, Buzzoni, R

Volltext

On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study von Holleczek, Bernd, Rossi, Silvia, Domenic, Agius, Innos, Kaire, Minicozzi, Pamela, Francisci, Silvia, Hackl, Monika, Eisemann, Nora, Brenner, Hermann

Volltext

P1.24 Loss of Succinate Dehydrogenase in Midgut Carcinoids as Prognostic Factor: A New Marker of Personalized Cancer Medicine in Neuroendocrine Tumours? von Milione, M., de Braud, F., Buzzoni, R., Pusceddu, S., Mazzaferro, V., Damato, A., Pelosi, G.

Volltext

Risk of second primary melanoma: how should be long follow-up be? Ratio of observed and expected cases von de Giorgi, V, Rossari, S, Papi, F, Buzzoni, C, Gori, A, Grazzini, M, Savarese, I, Crocetti, E, Longo, A S, Massi, D

Volltext

RISK OF HEMOLYMPHOPOIETIC NEOPLASM BEFORE AND AFTER THYROID CANCER. A POPULATION‐BASED STUDY IN ITALY, 1998‐2012 von Mattioli, V., Crocetti, E., Dal Maso, L., Buzzoni, C., Franceschi, S., Serraino, D., Vaccarella, S., Ferretti, S., Busco, S., Fedeli, U., Varvarà, M., Falcini, F., Zorzi, M., Carrozzi, G., Mazzucco, W., Gasparotti, C., Iacovacci, S., Toffolutti, F., Cavallo, R., Stracci, F., Russo, A. G., Caldarella, A., Rosso, S., Musolino, A., Mangone, L., Casella, C., Fusco, M., Tagliabue, G., Piras, D., Tumino, R., Guarda, L., Dinaro, Y. M., Piffer, S., Pinna, P., Mazzoleni, G., Fanetti, A. C.

Volltext

5'-Phosphoramidates and 5'-diphosphates of 2'-O-allyl-β-D-arabinofuranosyluracil, -cytosine, and -adenine : Inhibition of ribonucleotide reductase von MANFREDINI, S, GIOVANNI BARALDI, P, DURINI, E, VERTUANI, S, BALZARINI, J, DE CLERCQ, E, KARLSSON, A, BUZZONI, V, THELANDER, L

Volltext

5‘-Phosphoramidates and 5‘-Diphosphates of 2‘-O-Allyl-β-d-arabinofuranosyl- uracil, -cytosine, and -adenine:  Inhibition of Ribonucleotide Reductase von Manfredini, Stefano, Baraldi, Pier Giovanni, Durini, Elisa, Vertuani, Silvia, Balzarini, Jan, De Clercq, Erik, Karlsson, Anna, Buzzoni, Valentina, Thelander, Lars

Volltext

Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study von Baili, Paolo, Di Salvo, Francesca, Marcos-Gragera, Rafael, Siesling, Sabine, Mallone, Sandra, Santaquilani, Mariano, Micheli, Andrea, Lillini, Roberto, Francisci, Silvia

Volltext

Toluene ammoxidation on α-Fe2O3-based catalysts von ROMBI, E, FERINO, I, MONACI, R, PICCIAU, C, SOLINAS, V, BUZZONI, R

Volltext

Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer: Clinical Oncology/Epidemiology von Bajetta, E, Zilembo, N, Buzzoni, R, Noberasco, C, Di Leo, A, Bartoli, C, Merson, M, Sacchini, V, Moglia, D, Celio, L, Nelli, P

Volltext

Synthesis, Cytostatic Activity and Inhibition of Ribonucleotide Reductase by 5′-Phosphoramidates and 5′-Diphosphates, of 2′-O-Allyl-arabinofuranosyl Nucleosides von Manfredini, S., Baraldi, P. G., Durini, E., Balzarini, J., Clercq, E. De, Karlsson, A., Buzzoni, V., Thelander, L.

Volltext

A randomized study with 4-hydroxyandrostenedione (4-OHA) in postmenopausal advanced breast cancer (ABC): Characteristics of responsive patients von Bajetta, E., Zilembo, N., Buzzoni, R., Noberasco, C., Sacchini, V., La Monica, G., Bichisao, E.

Volltext

Salvage treatment after r-interferon alpha-2a in advanced neuroendocrine tumors von Zilembo, N, Buzzoni, R, Bajetta, E, Di Bartolomeo, M, de Braud, F, Castellani, R, Maffioli, L, Celio, L, Villa, E, Lorusso, V

Volltext